QOP
AGN

Quinn Opportunity Partners’s Allergan plc AGN Stock Holding History

Quinn Opportunity Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-93,800
Closed -$16.6M – 220
2020
Q1 		$16.6M Buy
+93,800
New +$17.7M 2.51% 7
2019
Q4 		– Sell
-144,000
Closed -$24.2M – 198
2019
Q3 		$24.2M Buy
144,000
+87,000
+153% +$14.2M 2.94% 7
2019
Q2 		$9.54M Buy
57,000
+37,600
+194% +$5.21M 1.19% 19
2019
Q1 		$2.84M Sell
19,400
-7,000
-27% -$1.01M 0.39% 44
2018
Q4 		$3.53M Buy
26,400
+5,150
+24% +$844K 0.49% 34
2018
Q3 		$4.05M Hold
21,250
– – 0.58% 36
2018
Q2 		$3.54M Hold
21,250
– – 0.47% 41
2018
Q1 		$3.58M Hold
21,250
– – 0.46% 45
2017
Q4 		$3.48M Buy
21,250
+3,700
+21% +$664K 0.57% 45
2017
Q3 		$3.6M Sell
17,550
-100
-0.6% -$23.3K 0.57% 44
2017
Q2 		$4.29M Sell
17,650
-900
-5% -$211K 0.71% 34
2017
Q1 		$4.43M Sell
18,550
-100
-0.5% -$23.3K 1.02% 27
2016
Q4 		$3.92M Buy
18,650
+9,600
+106% +$1.99M 1.18% 22
2016
Q3 		$2.08M Sell
9,050
-21,700
-71% -$5.3M 0.76% 31
2016
Q2 		$7.11M Sell
30,750
-29,200
-49% -$6.73M 2.77% 11
2016
Q1 		$16.1M Buy
59,950
+13,500
+29% +$3.86M 6.16% 4
2015
Q4 		$14.5M Buy
+46,450
New +$13.8M 6.39% 2
2015
Q3 		– Sell
-5,200
Closed -$1.58M – 132
2015
Q2 		$1.58M Hold
5,200
– – 0.75% 34
2015
Q1 		$1.55M Buy
5,200
+4,200
+420% +$1.2M 0.83% 30
2014
Q4 		$257K Buy
+1,000
New +$250K 0.12% 76

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Quinn Opportunity Partners's AGN Position: Q2 2020 in Review

Quinn Opportunity Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 93,800 shares — an estimated $16.6M sold.

Quinn Opportunity Partners first reported a position in AGN in Q4 2014 and held it in 20 quarters. The position peaked at $24.2M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Quinn Opportunity Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Quinn Opportunity Partners sold 93,800 Allergan plc shares in Q2 2020, an estimated $16.6M.
  • Quinn Opportunity Partners first reported a position in Allergan plc in Q4 2014 and held it in 20 quarters.
  • Quinn Opportunity Partners's Allergan plc position peaked at $24.2M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Quinn Opportunity Partners's 13F filing for Q2 2020, filed 14 Aug 2020.